The rapid development of coronavirus disease 2019 (COVID-19) vaccines has not been met with the assurance of an effective and equitable global distribution mechanism. Low-income countries are especially at-risk, with the price of the vaccines and supply shortages limiting their ability to procure and distribute the vaccines. While the COVAX initiative is one of the solutions to these challenges, vaccine nationalism has resulted in the hoarding of vaccines and the signing of parallel bilateral deals, undermining this formerly promising initiative. Moreover, inequity in local distribution also remains a problem, with clear discrimination of minorities and lack of logistical preparation in some countries. As we continue to distribute the COVID-19 vaccines, pharmaceutical companies should share their technology to increase supply and reduce prices, governments should prioritize equitable distribution to the most at- risk in all nations and low-income countries should bolster their logistical capacity in preparation for mass vaccination campaigns.
Mullard A. How COVID vaccines are being divvied up around the world. Nature. 2020. doi:10.1038/d41586-020-03370-6
Chigwedere P, Seage GR 3rd, Gruskin S, Lee TH, Essex M. Estimating the lost benefits of antiretroviral drug use in South Africa. J Acquir Immune Defic Syndr. 2008;49(4):410-415. doi:10.1097/qai.0b013e31818a6cd5
Fidler DP. Negotiating equitable access to influenza vaccines: global health diplomacy and the controversies surrounding avian influenza H5N1 and pandemic influenza H1N1. PLoS Med. 2010;7(5):e1000247. doi:10.1371/journal.pmed.1000247
Coronavirus: WHO chief criticises “shocking” global vaccine divide. BBC News. April 10, 2021. https://www.bbc.com/news/world-56698854. Accessed April 18, 2021.
Hill A, Khoo S, Fortunak J, Simmons B, Ford N. Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries. Clin Infect Dis. 2014;58(7):928-936. doi:10.1093/cid/ciu012
Binagwaho, A., Mathewos, K., & Davis, S. (2022). Equitable and Effective Distribution of the COVID-19 Vaccines – A Scientific and Moral Obligation. International Journal of Health Policy and Management, 11(2), 100-102. doi: 10.34172/ijhpm.2021.49
MLA
Agnes Binagwaho; Kedest Mathewos; Sheila Davis. "Equitable and Effective Distribution of the COVID-19 Vaccines – A Scientific and Moral Obligation". International Journal of Health Policy and Management, 11, 2, 2022, 100-102. doi: 10.34172/ijhpm.2021.49
HARVARD
Binagwaho, A., Mathewos, K., Davis, S. (2022). 'Equitable and Effective Distribution of the COVID-19 Vaccines – A Scientific and Moral Obligation', International Journal of Health Policy and Management, 11(2), pp. 100-102. doi: 10.34172/ijhpm.2021.49
VANCOUVER
Binagwaho, A., Mathewos, K., Davis, S. Equitable and Effective Distribution of the COVID-19 Vaccines – A Scientific and Moral Obligation. International Journal of Health Policy and Management, 2022; 11(2): 100-102. doi: 10.34172/ijhpm.2021.49